131 lines
4.3 KiB
Python
131 lines
4.3 KiB
Python
#!/usr/bin/env python3
|
|
"""
|
|
创建RVPH分析报告
|
|
"""
|
|
import json
|
|
from datetime import datetime
|
|
from analysis_storage import AnalysisStorage
|
|
|
|
def create_rvph_analysis():
|
|
"""创建RVPH的分析报告"""
|
|
|
|
# 基于网络搜索的数据创建分析结果
|
|
analysis_data = {
|
|
'company_info': {
|
|
'name': 'Reviva Pharmaceuticals Holdings, Inc.',
|
|
'symbol': 'RVPH',
|
|
'industry': 'Biotechnology',
|
|
'sector': 'Healthcare',
|
|
'market_cap': 17710000, # $17.71M
|
|
'employees': 14,
|
|
'website': 'https://www.revivapharma.com',
|
|
'country': 'United States',
|
|
'currency': 'USD'
|
|
},
|
|
'financial_data': {
|
|
'revenue': 0,
|
|
'net_income': -29100000, # -$29.1M
|
|
'total_assets': 15500000, # $15.5M
|
|
'total_liabilities': 14690000, # $14.69M
|
|
'cash': 1020000, # $1.02M
|
|
'debt': 0
|
|
},
|
|
'valuation_analysis': {
|
|
'pe_ratio': None, # 负盈利
|
|
'pb_ratio': None, # 负账面价值
|
|
'ps_ratio': None, # 无收入
|
|
'peg_ratio': None,
|
|
'market_cap': 17710000,
|
|
'enterprise_value': 7460000, # $7.46M
|
|
'valuation_score': 15, # 低估值分数
|
|
'is_undervalued': False
|
|
},
|
|
'financial_health': {
|
|
'current_ratio': 0.90,
|
|
'quick_ratio': 0.90,
|
|
'debt_to_equity': None,
|
|
'debt_ratio': 0.95, # 95%债务比率
|
|
'roe': -9.16, # -916%
|
|
'roa': -2.75, # -275%
|
|
'profit_margin': None, # 负值
|
|
'operating_margin': None, # 负值
|
|
'health_score': 10, # 极低健康度分数
|
|
'is_healthy': False
|
|
},
|
|
'growth_analysis': {
|
|
'revenue_growth': 0, # 无收入
|
|
'earnings_growth': 0, # 持续亏损
|
|
'historical_growth': 0,
|
|
'growth_score': 5, # 极低成长性分数
|
|
'is_growing': False
|
|
},
|
|
'risk_analysis': {
|
|
'beta': -0.06,
|
|
'volatility': 0.894, # 89.4%
|
|
'max_drawdown': 0.93, # 93%最大回撤
|
|
'risk_score': 20, # 高风险分数
|
|
'risk_level': '极高'
|
|
},
|
|
'investment_recommendation': {
|
|
'recommendation': '观望/高风险投机',
|
|
'confidence': '高',
|
|
'overall_score': 35, # 35/100分
|
|
'risk_warnings': [
|
|
'极高风险投资',
|
|
'财务健康度极差',
|
|
'无收入来源',
|
|
'持续亏损',
|
|
'依赖融资维持运营',
|
|
'监管审批不确定性',
|
|
'可能完全损失本金'
|
|
],
|
|
'key_strengths': [
|
|
'专注精神分裂症治疗',
|
|
'主要产品临床试验积极',
|
|
'分析师全部给予买入评级',
|
|
'获得FDA对齐'
|
|
],
|
|
'key_concerns': [
|
|
'无商业化产品',
|
|
'持续亏损',
|
|
'高债务比率',
|
|
'股价大幅下跌',
|
|
'流动性风险'
|
|
]
|
|
},
|
|
'analyst_opinions': {
|
|
'total_analysts': 13,
|
|
'buy_ratings': 13,
|
|
'hold_ratings': 0,
|
|
'sell_ratings': 0,
|
|
'average_target_price': 14.46,
|
|
'price_target_range': '2.00 - 20.00'
|
|
},
|
|
'market_data': {
|
|
'current_price': 0.26,
|
|
'previous_close': 0.42,
|
|
'day_change': -0.16,
|
|
'day_change_percent': -37.89,
|
|
'volume': 29973974,
|
|
'avg_volume': 2720000,
|
|
'market_cap': 17710000,
|
|
'shares_outstanding': 68000000,
|
|
'float': 60810000,
|
|
'insider_ownership': 10.59,
|
|
'institutional_ownership': 21.25
|
|
}
|
|
}
|
|
|
|
# 保存分析报告
|
|
storage = AnalysisStorage()
|
|
result = storage.save_analysis_report('RVPH', analysis_data)
|
|
|
|
print("✅ RVPH分析报告已创建并保存")
|
|
print(f"📁 详细报告: {result.get('detailed_report', 'N/A')}")
|
|
print(f"📄 简要报告: {result.get('summary_report', 'N/A')}")
|
|
print(f"💾 原始数据: {result.get('raw_data', 'N/A')}")
|
|
|
|
return result
|
|
|
|
if __name__ == "__main__":
|
|
create_rvph_analysis() |